α-adducin Gly460Trp variant increases the risk of stroke in hypertensive Dutch women

Hypertension

Volumn 51, Issue 6, 2008, Pages 1665-1670

  Zafarmand, Mohammad Hadi ^a,b   Van Der Schouw, Yvonne T ^a   Grobbee, Diederick E ^a   De Leeuw, Peter W ^c   Bots, Michiel L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Case cohort studies; Cerebrovascular disorders; Coronary artery disease; Genetics; Ischemic stroke; Myocardial infarction; Polymorphism

Indexed keywords

ALPHA ADDUCIN; GLYCINE; SODIUM CHLORIDE; TRYPTOPHAN; ADDUCIN; CALMODULIN BINDING PROTEIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CASE STUDY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOMINANT INHERITANCE; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM RETENTION; STROKE; SUBARACHNOID HEMORRHAGE; SYSTOLIC HYPERTENSION; BRAIN ISCHEMIA; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HYPERTENSION; MIDDLE AGED; NETHERLANDS; RISK FACTOR;

AGED; BRAIN ISCHEMIA; CALMODULIN-BINDING PROTEINS; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; VARIATION (GENETICS);

EID: 45849113236     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.112458     Document Type: Article

References (25)

1. Bianchi G, Ferrari P, Staessen JA. Adducin polymorphism: detection and impact on hypertension and related disorders. Hypertension. 2005;45: 331-340.
2. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet. 1997;349:1353-1357.
3. Franco V, Oparil S. Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival. J Am Coll Nutr. 2006;25:247S-255S.
4. Psaty BM, Smith NL, Heckbert SR, Vos HL, Lemaitre RN, Reiner AP, Siscovick DS, Bis J, Lumley T, Longstreth WT Jr, Rosendaal FR. Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. JAMA. 2002; 287:1680-1689.
5. van Rijn MJ, Bos MJ, Yazdanpanah M, Isaacs A, rias-Vasquez A, Koudstaal PJ, Hofman A, Witteman JC, van Duijn CM, Breteler MM. Alpha-adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular risk. Stroke. 006;37:2930-2934.
6. Li Y, Thijs L, Kuznetsova T, Zagato L, Struijker-Boudier H, Bianchi G, Staessen JA. Cardiovascular risk in relation to alpha-adducin Gly460Trp polymorphism and systolic pressure: a prospective population study. Hypertension. 2005;46:527-532.
7. Morrison AC, Doris PA, Folsom AR, Nieto FJ, Boerwinkle E. G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke. 2001;32:822-829.
8. Boker LK, van Noord PA, van der Schouw YT, Koot NV, Bueno de Mesquita HB, Riboli E, Grobbee DE, Peeters PH. Prospect-EPIC Utrecht:study design and characteristics of the cohort population. European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol. 2001;17:1047-1053.
9. Herings RM, Bakker A, Stricker BH, Nap G. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health. 1992;46:136-140.
10. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 1986;73:1-11.
11. Izzo JL Jr, Levy D, Black HR. Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension. 2000;35:1021-1024.
12. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, Chen JJ, Pullinger CR, Malloy MJ, Siest G, Kane JP. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res.1999;9:936- 949.
13. Onland-Moret NC, van der ADL, van der Schouw YT, Buschers W, Elias SG, van Gils CH, Koerselman J, Roest M, Grobbee DE, Peeters PH. Analysis of case-cohort data: a comparison of different methods. J Clin Epidemiol. 2007;60:350-355.
14. Sauerbrei W, Royston P, Bojar H, Schmoor C, Schumacher M. Modelling. the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG). Br J Cancer.1999;79:1752-1760.
15. Botto LD, Khoury MJ. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol. 2001;153:1016-1020.
16. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3:452-456.
17. Knol MJ, van dT, I, Grobbee DE, Numans ME, Geerlings MI. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol. 2007;36:1111-1118.
18. Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol. 2007;17:227-236.
19. Rothman KJ, Greenland S, Walker AM. Concepts of interaction. Am J Epidemiol. 1980;112:467-470.
20. Ju Z, Zhang H, Sun K, Song Y, Lu H, Hui R, Huang X. Alpha-adducin gene polymorphism is associated with essential hypertension in Chinese: a case-control and family-based study. J Hypertens. 2003;21:1861-1868.
21. Niu T, Xu X, Cordell HJ, Rogus J, Zhou Y, Fang Z, Lindpaintner K. Linkage analysis of candidate genes and gene-gene interactions in Chinese hypertensive sib pairs. Hypertension. 1999;33:1332-1337.
22. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255-3264.
23. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350:757-764.
24. Manunta P, Cerutti R, Bernardi L, Stella P, Bianchi G. Renal genetic mechanisms of essential hypertension. J Nephrol. 1997;10:172-178.
25. Volpe M, Iaccarino G, Vecchione C, Rizzoni D, Russo R, Rubattu S, Condorelli G, Ganten U, Ganten D, Trimarco B, Lindpaintner K. Association and cosegregation of stroke with impaired endothelium-dependent vasorelaxation in stroke prone, spontaneously hypertensive rats. J Clin Invest. 1996;98:256-261.